BioSpace News Archive

Biotech Bay

3 Small-Cap Biotechs That Have Big News on the Way in 2018

More excitement should lie ahead for these small-cap biotechs this year.

January 8, 2018
·
1 min read
Pharm Country

Bristol-Myers to Take a $3B Tax Hit in Q4 2017

The expense is primarily related to taxes on unremitted offshore earnings, the company said.

January 8, 2018
·
1 min read
Policy

pSivida Submits NDA for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA

The FDA will next determine whether pSivida’s NDA is complete and acceptable for review.

January 8, 2018
·
6 min read
Drug Development

The “Magic Word” That Can Trigger a Drugmaker’s Stock to Soar

A look at the lucky drugs that have been hailed a breakthrough by the FDA.

January 8, 2018
·
1 min read
FDA

Will 2018 Be Another Record Year for FDA Approvals?

2017 was the second-best year for FDA approvals since 1996.

January 8, 2018
·
1 min read
Drug Development

Biotech Unicorn Moderna Details Game Plan, Reveals Infectious Disease Programs

Moderna unleashed a torrent of updates yesterday.

January 8, 2018
·
2 min read
·
Mark Terry
Business

Effective January 15th: Perrigo CEO Retires, New Leader Named

Perrigo today announced the appointment of Uwe Rohrhoff as Chief Executive Officer, effective January 15, 2018, following the retirement of John T. Hendrickson.

January 8, 2018
·
7 min read
Business

Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi

Evotec and Apeiron announced today that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015.

January 8, 2018
·
5 min read
ANGLE plc: Prostate Cancer ARV7 Treatment Biomarker

Measurement of the expression of ARV7 on circulating tumor cells (CTCs) obtained from a blood test1 has previously been studied and found to correlate with patient response to novel hormone therapy (NHT) drugs (Enzalutamide and Abiraterone).

January 8, 2018
·
7 min read
FDA

Axonics Sacral Neuromodulation System Receives Marketing Approval in Australia

This approval confirms that the Axonics r-SNM System meets all of the Australian Medical Devices Regulations for Active Implantable Medical Devices and enables commercialization throughout Australia.

January 8, 2018
·
2 min read